As-Needed Albuterol–Budesonide Therapy in Mild Asthma: Clinical Impact and Comparative Evidence
Highlights
– As-needed albuterol–budesonide reduces severe exacerbations in mild asthma compared to as-needed albuterol alone.
– Combination therapy leads to lower systemic glucocorticoid use and preserves rapid bronchodilation.
– Efficacy and safety are confirmed in large, rigorously designed randomized controlled trials.
Clinical Background and Disease Burden
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.